Showing results (41-50 of 92) with videos related to
Sort By:
Pageof 10
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 28, 2011
Effect of treatment with natalizumab on ability to work in people with multiple sclerosis: productivity gain based on direct measurement of work capacity before and after 1 year of treatmentSara Olofsson, Anne Wickström, Anna Häger Glenngård, et al.Journal of Health Economics and Outcomes Research|August 25, 2021
Willingness-to-pay to access Ingenol Mebutate Gel for Actinic Keratosis Treatment in the U.S. SettingMichael Willis, Sandra Erntoft, Sofie Persson, et al.Dermatology (Basel, Switzerland)|January 19, 2013
Switch to biological agent in psoriasis significantly improved clinical and patient-reported outcomes in real-world practiceJenny M Norlin, Katarina Steen Carlsson, Ulf Persson, et al.Vaccine|May 7, 2022
Acceptance and application of a broad population health perspective when evaluating vaccineUlf Persson, Sara Olofsson, Rikard Althin, et al.Therapeutic Advances in Musculoskeletal Disease|February 6, 2023
Cost-effectiveness of specialised manual therapy versus orthopaedic care for musculoskeletal disorders: long-term follow-up and health economic modelStina Lilje, Maurits van Tulder, Anders Wykman, et al.Acta Dermato-Venereologica|May 14, 2014
Resource use in patients with psoriasis after the introduction of biologics in SwedenJenny M Norlin, Katarina Steen Carlsson, Ulf Persson, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 17, 2015
Register-Based Evaluation of Relative Effectiveness of New Therapies: Biologics Versus Conventional Agents in Treatment of Psoriasis in SwedenJenny M Norlin, Katarina Steen Carlsson, Ulf Persson, et al.Acta Oncologica (Stockholm, Sweden)|April 29, 2016
Cost effectiveness of pomalidomide in patients with relapsed and refractory multiple myeloma in SwedenSixten Borg, Hareth Nahi, Markus Hansson, et al.Schizophrenia Research and Treatment|September 12, 2012
Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of Risperidone Long-Acting InjectionChristian Asseburg, Michael Willis, Mickael Löthgren, et al.Chiropractic & Manual Therapies|May 16, 2022
Manual therapy versus advice to stay active for nonspecific back and/or neck pain: a cost-effectiveness analysisEmmanuel Aboagye, Stina Lilje, Camilla Bengtsson, et al.Pageof 10